Trails Center.org

Clinical Trial Name - Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea

 
Original Study ID : IKH-01-4
NCT ID : NCT00212342
Brief Title : Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea
Official Title : Phase 3,Placebo Controlled,Randomized,Double-Blinded,NSAID-Add-on,Clinical Trial of Mono-Phase Low Dose Oral Contraceptive Pill for Treatment of Dysmenorrhea Associated With Endometriosis.
Brief Summary :

The purpose of this study is to determine whether combination oral contraceptive pill of Norethindrone & Ethinyl estradiol is effective in the treatment of dysmenorrhea associated with endometriosis.

Source : Nobelpharma
Overall Status : Completed
Official Title : Phase 3
Phase : Interventional
Study Design : Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Verification Date : May 2009
First Received Date : September 13, 2005
Trial Eligibility
Criteria :
Inclusion Criteria:

- dysmenorrhea associated with endometriosis

Exclusion Criteria:

- severe hepatopathy

- pregnant woman
Gender : Female
Minimum Age : 18 Years
Maximum Age : N/A
Healthy Volunteers : No
OutComes
Primary OutComes
Measure : patient response to treatment for dysmenorrhea associated with endometriosis,as evaluated by VRS
Secondary OutComes
Measure : changes in the VAS of dysmenorrhea.
Measure : changes in the VRS of non-menstrual pain.
Measure : changes in the VAS of non-menstrual pain.
Measure : changes in the clinical evaluation of pelvic induration.
Measure : changes in the size of ovarian endometrioma.
Interventions
Type : Drug
Name : Norethindrone,Ethinyl Estradiol
 
Search Trials By
Search
 
Research
 
 
Most Popular Trials
 
Library
 
Discuss